FINHUB Insights

Biogen

BIIB Health Care Market cap $32.1B as of Sep 14, 2026 16:00 ET S&P 500

252 of 416 with a diagram, by size

Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 29, 2026

Revenue$2.48B +2% year over year
Gross profit$1.82B 73% margin
Operating profit$0.46B 19% margin
Net profit$0.32B 13% margin

100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Already have an account? Sign in

The numbers behind the diagram
All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 2.48 100% +2%
Cost of revenue−0.6627%
Gross profit1.8273% margin−1pp
SG&A−0.6125%+1pp
Other−0.7530%+0pp
Operating profit0.4619% margin+0pp
Interest & other costs−0.08
Tax−0.06
Net profit0.32 13% margin+3pp

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

The balance sheet, capital flow, debt schedule and capital structure open with a free account.

Quarter by quarter

So far we hold one set of results. Another one arrives with the next filing.

Quarter Period Reported Revenue Year over year Operating margin Net profit Net margin
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 29, 2026 Operating margin 19% Net profit $0.32B Jan 1 – Mar 31, 2026 Apr 29, 2026 $2.5B +2% 19% $0.32B 13%